Granite Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.03M Sell
9,132
-297
-3% -$99.7K 0.49% 78
2021
Q2
$2.89M Sell
9,429
-2,478
-21% -$695K 0.45% 78
2021
Q1
$2.93M Buy
11,907
+333
+3% +$83.8K 0.49% 77
2020
Q4
$3.16M Sell
11,574
-3,942
-25% -$979K 0.56% 65
2020
Q3
$3.67M Buy
15,516
+1,155
+8% +$259K 0.72% 55
2020
Q2
$2.73M Buy
14,361
+300
+2% +$53.8K 0.59% 63
2020
Q1
$2.32M Buy
14,061
+11,805
+523% +$2.16M 0.58% 60
2019
Q4
$445K Sell
2,256
-8,718
-79% -$1.63M 0.08% 120
2019
Q3
$1.98M Sell
10,974
-5,790
-35% -$1M 0.39% 81
2019
Q2
$2.93M Buy
16,764
+7,614
+83% +$1.3M 0.55% 62
2019
Q1
$1.74M Buy
+9,150
New +$1.63M 0.33% 81
2018
Q1
Sell
-11,208
Closed -$1.36M 177
2017
Q4
$1.36M Buy
+11,208
New +$1.4M 0.24% 103

Other funds holding ISRG

Granite Investment Advisors's ISRG Position: Q3 2021 in Review

Granite Investment Advisors reduced its Intuitive Surgical (ISRG) stake by 3.1% in Q3 2021, selling an estimated $99.7K and leaving 9,132 shares worth $3.03M. The position accounts for 0.49% of the portfolio, ranked #78.

Granite Investment Advisors first reported a position in ISRG in Q4 2017 and has held it in 12 quarters since. The position peaked at $3.67M in Q3 2020. 1,372 funds tracked by Wall St. Rank hold ISRG as of Q3 2021.

  • Granite Investment Advisors held 9,132 shares of Intuitive Surgical worth $3.03M as of Q3 2021.
  • Granite Investment Advisors sold 297 Intuitive Surgical shares in Q3 2021, an estimated $99.7K.
  • Intuitive Surgical made up 0.49% of Granite Investment Advisors's portfolio in Q3 2021, its #78 holding.
  • Granite Investment Advisors first reported a position in Intuitive Surgical in Q4 2017 and has held it in 12 quarters since.
  • Granite Investment Advisors's Intuitive Surgical position peaked at $3.67M in Q3 2020.
  • 1,372 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2021.

Based on Granite Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.